Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 29;23(1):76.
doi: 10.1186/s12931-022-01997-9.

Local nebulization of 1α,25(OH)2D3 attenuates LPS-induced acute lung inflammation

Affiliations

Local nebulization of 1α,25(OH)2D3 attenuates LPS-induced acute lung inflammation

Jef Serré et al. Respir Res. .

Abstract

Background: Evidence supports a critical role of vitamin D status on exacerbation in chronic obstructive pulmonary disease, indicating the need to avoid vitamin D deficiency in these patients. However, oral vitamin D supplementation is limited by the potential risk for hypercalcemia. In this study, we investigated if local delivery of vitamin D to the lungs improves vitamin D-mediated anti-inflammatory action in response to acute inflammation without inducing hypercalcemia.

Methods: We studied vitamin D sufficient (VDS) or deficient (VDD) mice in whom 1α,25(OH)2D3 (0.2 μg/kg) or a vehicle followed by lipopolysaccharide (LPS 25 µg) were delivered to the lung as a micro-spray.

Results: Local 1α,25(OH)2D3 reduced LPS-induced inflammatory cells in bronchoalveolar lavage (BAL) in VDS (absolute number of cells: - 57% and neutrophils - 51% p < 0.01) and tended to diminish LPS-increased CXCL5 BAL levels in VDS (- 40%, p = 0.05) while it had no effect on CXCL1 and CXCL2 in BAL and mRNA in lung of VDS and VDD. It also significantly attenuated the increased IL-13 in BAL and lung, especially in VDD mice (- 41 and - 75%, respectively). mRNA expression of Claudin-18 in lung was significantly lower in VDS mice with local 1α,25(OH)2D3 while Claudin-3, -5 and -8 mRNA levels remained unchanged. Finally, in VDD mice only, LPS reduced lung mRNA expression of adhesion junction Zona-occludens-1, in addition to increasing uric acid and total protein in BAL, which both were prevented by local 1α,25(OH)2D3.

Conclusion: Under normal levels of vitamin D, local 1α,25(OH)2D3 nebulization into the lung efficiently reduced LPS induction of inflammatory cells in BAL and slightly attenuated LPS-increase in CXCL5. In case of severe vitamin D deficiency, although local 1α,25(OH)2D3 nebulization failed to significantly minimize cellular inflammation in BAL at this dose, it prevented epithelial barrier leakage and damage in lung. Additional research is needed to determine the potential long-term beneficial effects of local 1α,25(OH)2D3 nebulization on lung inflammation.

Keywords: Acute lung inflammation; Local vitamin D nebulization; Vitamin D deficiency.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any conflicts of interest to disclose in relation with this manuscript. The authors confirm that the work described has not been published previously, is not under consideration for publication elsewhere, and its publication has been approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form in English or in any other language, without the written consent of the copyright holder.

Figures

Fig. 1
Fig. 1
Study design. Three-week old male mice were fed a vitamin D deficient or standard control diet during the whole study period. At the age of 8–9 weeks, mice were instilled via an aerosolizer syringe with 0.2 μg/kg 1α,25(OH)2D3 or a vehicle 2 h prior to a 25 μg LPS instillation and measurements were performed 24 h later
Fig. 2
Fig. 2
Absolute number of total cells (A), neutrophils (B) and macrophages (C) in BAL of vitamin D sufficient or deficient mice treated either with vehicle (open circles) or 1α,25(OH)2D3 (closed circles) followed by LPS. NS: not significant, **: p < 0.01 (Kruskal–Wallis); ##: p < 0.01 (Mann–Whitney). Data are expressed as median ± IQR
Fig. 3
Fig. 3
Chemokines A CXCL1, B CXCL2 and C CXCL5 in BAL and mRNA expression of D CXCL1, E CXCL2 and F CXCL5 in lung homogenate in vitamin D sufficient or deficient mice treated either with vehicle (open circles) or 1α,25(OH)2D3 (closed circles) followed by LPS. mRNA data expressed relative to RPL27. NS: not significant, φ: p = 0.05 (Mann Whitney). Data are expressed as median ± IQR
Fig. 4
Fig. 4
Lung mRNA expression of tight junctions namely claudin (Cldn) 3 (A), 5 (B), 8 (C) and 18 (D) and adhesion junction Zona occludens-1 (ZO-1) (E) in vitamin D sufficient or deficient mice treated either with vehicle (open circles) or 1α,25(OH)2D3 (closed circles) followed by LPS. mRNA data expressed relative to RPL27. * and #: p < 0.05 (Kruskal–Wallis and Mann Whitney); +  + : p < 0.01 (Mann Whitney). Data are expressed as median ± IQR
Fig. 5
Fig. 5
Protein (A) and uric acid (B) concentration in BAL fluid expressed as µg/ml and µM, respectively and serum Surfactant protein-D (SP-D) concentration expressed as pg/ml measured in vitamin D sufficient or deficient mice treated either with vehicle (open circles) or 1α,25(OH)2D3 (closed circles) followed by LPS. NS: not significant, ***: p < 0.001 (Kruskal–Wallis); φ: p = 0.05 (Mann Whitney); #: p < 0.05 (Mann Whitney); ###: p < 0.001 (Mann Whitney) +++ : p < 0.005 (Mann Whitney). Data are expressed as median ± IQR

References

    1. 2020 Gold Reports. Glob. Initiat. Chronic Obstr. Lung Dis. - GOLD. [cited 2021 Feb 9]. https://goldcopd.org/gold-reports/
    1. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–1613. - PubMed
    1. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. - PubMed
    1. Donaldson GC, Seemungal TR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852. - PMC - PubMed
    1. Donaldson GC, Wilkinson TMA, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:446–452. - PubMed

Grants and funding

LinkOut - more resources